Theodora Bejan-Angoulvant

10PUBLICATIONS
22CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedDecision makingMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 07, 2026
Fibrosis and hypertension: association but not causation.

|May 04, 2026
Potassium on the Spot: interpreting cardiovascular risk in CKD.

|Nov 04, 2025
Renal Histology Findings in Malignant Hypertension, a Systematic Review.

Valentin Maisons, Ferhat Demir, Alexandre Fillon

|Sep 23, 2025
Targets for treatment and optimal strategies for managing hypertension in 2025: indications for clinical practice from recent hypertension guidelines.

Bert-Jan H van den Born, Theodora Bejan-Angoulvant, Martino F Pengo

|Apr 15, 2025
SGLT2 inhibitors: towards a personalized prescription.

Jean-Baptiste de Freminville, Theodora Bejan-Angoulvant

|Jan 19, 2022
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model.

Olivier Le Tilly, Philippe Gatault, Christophe Baron

Pageof 2

Frequent Collaborators

2 joint publications

David Ternant

1 joint publications

Débora Lanznaster

1 joint publications

Denis Mulleman

1 joint publications

Olivier Le Tilly